News Releases

Value in Cancer Care Initiative Town Hall welcomes input on oncology value measures

Scott Ramsey, Gary Lyman

Dr. Gary Lyman (left) and Dr. Scott Ramsey (right) are co-directors of the Hutchinson Institute for Cancer Outcomes Research.

Photo credit: Bo Jungmayer / Fred Hutch file

SEATTLE – May 16, 2014 –The Value in Cancer Care Initiative, part of the Hutchinson Institute for Cancer Outcomes Research, will hold a public forum on Monday, May 19 from 3 to 5 p.m.

The public forum is an interactive and inclusive process that will provide an opportunity for attendees to discuss and refine the top six value metrics in oncology, which originated from the Value in Cancer Care Summit held in January. Participants also will be asked to help identify the next steps and continue the dialogue around reducing the economic and human burden of cancer in our region.

The top six metrics that will be discussed during the forum are: end-of-life chemotherapy, coordinated care, palliative care, guideline adherence, biomarkers and hospital admission.

The Town Hall kicks off with a keynote address by Daniel Wolfson, executive vice president and chief operating officer of the American Board of Internal Medicine Foundation. Wolfson will update the community on the national ABIM Choosing Wisely Campaign in oncology. HICOR’s Value in Cancer Care Initiative is a coalition of health care provider groups, health insurers, businesses and patient groups that are working to define, collect and share oncology value measures in Washington state.

The Town Hall is open to the public and will take place at the Robert M. Arnold Building on the campus of Fred Hutchinson Cancer Research Center, 1100 Fairview Ave. N., Seattle, Wash., 98109. For additional information and to RSVP please visit: www.fhcrc.org/valueinitiative

Editor’s note: Info about photos, interview availability, etc., if needed.

# # #

At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer with minimal side effects. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first and largest cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network. Private contributions are essential for enabling Fred Hutch scientists to explore novel research opportunities that lead to important medical breakthroughs. For more information visit www.fredhutch.org or follow Fred Hutch on Facebook, Twitter or YouTube.

CONTACT
Michael Nank
206-667-2210
media@fredhutch.org

Fred Hutchinson Cancer Research Center is a world leader in research to prevent, detect and treat cancer and other life-threatening diseases.